Purdue Pharma is pushing for a massive settlement to deal with thousands of opioid-related lawsuits.
“Seeing something and saying something” can be applied to the life sciences when a lack of transparency could result in a company facing stiff regulatory action.
What’s causing drug companies to go bust
A new report shows that the number of FDA approvals for cancer drugs has shot up in the last few decades. What’s behind the rise?